Pituitary TumorCancer
What this study is
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.
Study details
- Official title
- Pituitary Tumor Surveillance: Pathogenetic Correlation
- Sponsor
- Cedars-Sinai Medical Center
- Conditions
- Pituitary Tumor
- Enrolling
- 1,250 people
- Starts
- 1997-01
- Est. completion
- 2050-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Patients with confirmed pituitary disease
You can't join if
- Patients who do not have confirmed pituitary disease
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openCedars-Sinai Medical Center, Pituitary Center
Los Angeles, California, United States
- Daniel Gomez · Contact424-315-2362daniel.gomez@cshs.org
- Shlomo Melmed, MD · Principal investigator
Recruiting
Study team
Sponsor
Cedars-Sinai Medical Center
Study ID 2873
Principal investigator
Shlomo Melmed, MD
Cedars-Sinai Medical Center, Pituitary Center
Have questions? The record lists no central contact. Use Consider me and the site team can reach you, or find them through ClinicalTrials.gov ↗.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.